Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo [NA]

View source ↗

Summary

A completed clinical trial evaluated whether daily supplementation with Lactobacillus acidophilus MPH734 for one week improves lactose metabolism, gastrointesti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus acidophilus MPH734

Snippet

Sponsor: Lemuel W. Taylor IV | Conditions: Lactose Intolerance | NA | Status: COMPLETED